RESULTS	The baseline characteristics of the exenatide QW ( 215 patients ) and insulin glargine ( 212 patients ) treatment groups were similar : mean ( SD ) age , 57 ( 10 ) years and 56 ( 11 ) years , respectively ; 66.0 % and 69.8 % male ; mean HbA ( 1c ) , 8.5 % ( 0.82 % ) and 8.5 % ( 0.79 % ) ; and mean weight , 69.9 ( 13.2 ) kg and 71.0 ( 13.9 ) kg .\